DENTSPLY SIRONA Inc.
XRAYNASDAQHealthcare● Active
$10.26
+$0.26(+2.60%)
Market Cap$2.1B
P/E Ratio—
52W High$17.09
52W Low$9.41
DENTSPLY SIRONA Inc. (XRAY) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · XRAY · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.60B) | ($0.91B) | ($0.13B) | ($0.95B) | $0.41B |
| Depreciation & Amort. | $0.35B | $0.35B | $0.34B | $0.33B | $0.35B |
| Stock-Based Comp. | $0.03B | $0.04B | $0.05B | $0.06B | $0.05B |
| Change in Working Capital | ($0.22B) | $0.10B | ($0.09B) | ($0.08B) | ($0.13B) |
| Net Cash from Operations | $0.23B | $0.46B | $0.38B | $0.52B | $0.66B |
| Investing Activities | |||||
| Capital Expenditure | ($0.13B) | ($0.18B) | ($0.15B) | ($0.15B) | ($0.14B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Net Cash from Investing | ($0.13B) | ($0.20B) | ($0.09B) | ($0.14B) | ($0.36B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | ($0.25B) | ($0.30B) | ($0.15B) | ($0.20B) |
| Dividends Paid | ($0.13B) | ($0.13B) | ($0.12B) | ($0.10B) | ($0.09B) |
| Debt Issued / Repaid | $0.05B | $0.09B | $0.12B | ($0.06B) | ($0.10B) |
| Net Cash from Financing | ($0.08B) | ($0.30B) | ($0.31B) | ($0.33B) | ($0.38B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.10B | $0.28B | $0.23B | $0.37B | $0.52B |
| FCF Margin %(computed) | 2.83% | 7.41% | 5.75% | 9.38% | 12.17% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more DENTSPLY SIRONA Inc. data
About DENTSPLY SIRONA Inc. (XRAY) Cash Flow Statement
DENTSPLY SIRONA Inc. generated operating cash flow of $0.23B and free cash flow of $0.10B for 2025 — a FCF margin of 2.83%. Capital expenditure was ($0.13B).
Frequently asked questions
XRAY · 4 questionsDENTSPLY SIRONA Inc. generated free cash flow of $0.10B for 2025, down 63.0% year-over-year.
XRAY free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10